Product Information
BRIMONIDINE TARTRATE 0.15% DRP is a generic product labeled by Alembic Pharmaceuticals Inc., priced at $9.7473 per ML under NDC 62332066105. Its NADAC has been published 161 times since Sep 6, 2023.
FDA first approved this application on Mar 29, 2023. Its Orange Book therapeutic-equivalence code is AT.
Strength
1.5 mg/mL
Manufacturer
Alembic Pharmaceuticals Inc.NDC
62332066105
Classification
Generic
Dosage Form
SOLUTION/ DROPS
Route
OPHTHALMIC
Effective Date
9/23/2026
Active Ingredients
BRIMONIDINE TARTRATEApproval Type
Generic (ANDA)
FDA Application
ANDA215225FDA Approved
3/29/2023
TE Code
AT
On Market Since
3/29/2023
Pharmacological Classes
Price Statistics
The NADAC for BRIMONIDINE TARTRATE 0.15% DRP has been published 161 times since Sep 6, 2023, and over the history we have for it it has declined 55.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $9.7473 per ML |
|---|---|
| All-time high | $24.3580 (Dec 13, 2023) |
| All-time low | $9.7473 (Sep 23, 2026) |
| 52-week high | $12.2783 |
| 52-week low | $9.7473 |
| Median price | $12.6197 |
| Average price | $14.2461 |
| Largest weekly change | +38.2% (Aug 21, 2024) |
| Weeks tracked | 161 |
| Tracking since | Sep 6, 2023 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Alembic Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Brimonidine Tartrate ophthalmic solution, 0.15% market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
alpha-Adrenergic Agonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of BRIMONIDINE TARTRATE 0.15% DRP?
The current National Average Drug Acquisition Cost (NADAC) for BRIMONIDINE TARTRATE 0.15% DRP, manufactured by Alembic Pharmaceuticals Inc., is $9.7473 per ML (NDC 62332066105), effective Sep 30, 2026.
How has the price of BRIMONIDINE TARTRATE 0.15% DRP changed over time?
Over the history we have for it, the NADAC for BRIMONIDINE TARTRATE 0.15% DRP has declined 55.5%. It has been tracked across 161 weekly CMS publications since Sep 6, 2023.
What are the highest and lowest recorded NADAC prices for BRIMONIDINE TARTRATE 0.15% DRP?
Since Sep 6, 2023, the NADAC for BRIMONIDINE TARTRATE 0.15% DRP has ranged from a low of $9.7473 (Sep 23, 2026) to a high of $24.3580 (Dec 13, 2023), with a median of $12.6197 per ML.
Are there cheaper alternatives to BRIMONIDINE TARTRATE 0.15% DRP?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as BRIMONIDINE TARTRATE 0.15% DRP in a comparable dosage form, but none are currently priced below it.
Who manufactures BRIMONIDINE TARTRATE 0.15% DRP?
BRIMONIDINE TARTRATE 0.15% DRP (NDC 62332066105) is labeled by Alembic Pharmaceuticals Inc., and CMS classifies it as a generic product.